{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:11:54Z","timestamp":1790284314491,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004519","name":"Tian Yuan Mathematical Foundation","doi-asserted-by":"publisher","award":["12026602"],"award-info":[{"award-number":["12026602"]}],"id":[{"id":"10.13039\/501100004519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012149","name":"National Key Scientific Instrument and Equipment Development Projects of China","doi-asserted-by":"publisher","award":["81627805"],"award-info":[{"award-number":["81627805"]}],"id":[{"id":"10.13039\/501100012149","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06983-5","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T13:27:55Z","timestamp":1755610075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CX26 promotes pancreatic cancer progression by competitively inhibiting interaction of c-Myc with PSMD2 and enhancing c-Myc stability"],"prefix":"10.1186","volume":"23","author":[{"given":"Cheng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"3","key":"6983_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Ca Cancer J Clin"},{"issue":"4","key":"6983_CR2","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4(4):e214708\u2013e214708.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"6983_CR3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jnci\/djaa004","volume":"112","author":"AL Blackford","year":"2020","unstructured":"Blackford AL, Canto MI, Klein AP, et al. Recent trends in the incidence and survival of stage 1A pancreatic cancer: a surveillance, epidemiology, and end results analysis. J Natl Cancer Inst. 2020;112(11):1162\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"6983_CR4","first-page":"1","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH, Neoptolemos JP. Pancreatic cancer. Nat Rev Dis Prim. 2016;2(1):1\u201322.","journal-title":"Nat Rev Dis Prim"},{"issue":"4","key":"6983_CR5","first-page":"305","volume":"69","author":"WS El-Deiry","year":"2019","unstructured":"El-Deiry WS, Goldberg RM, Lenz H-J, et al. The current state of molecular testing in the treatment of patients with solid tumors, 2019. Ca Cancer J Clin. 2019;69(4):305\u201343.","journal-title":"Ca Cancer J Clin"},{"key":"6983_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","volume":"834","author":"YT Lee","year":"2018","unstructured":"Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188\u201396.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"6983_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22\u201335.","journal-title":"Cell"},{"issue":"1","key":"6983_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4254\/wjh.v2.i1.16","volume":"2","author":"C-P Lin","year":"2010","unstructured":"Lin C-P, Liu C-R, Lee C-N, et al. Targeting c-Myc as a novel approach for hepatocellular carcinoma. World J Hepatol. 2010;2(1):16\u201320.","journal-title":"World J Hepatol"},{"issue":"22","key":"6983_CR9","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1158\/0008-5472.CAN-14-2345","volume":"75","author":"S Jain","year":"2015","unstructured":"Jain S, Wang X, Chang C-C, et al. Src inhibition blocks c-Myc translation and glucose metabolism to prevent the development of breast cancer. Cancer Res. 2015;75(22):4863\u201375.","journal-title":"Cancer Res"},{"issue":"4","key":"6983_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/modpathol.3880547","volume":"15","author":"C Schleger","year":"2002","unstructured":"Schleger C, Verbeke C, Hildenbrand R, et al. C-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance. Mod Pathol. 2002;15(4):462\u20139.","journal-title":"Mod Pathol"},{"issue":"4","key":"6983_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1158\/2159-8290.CD-19-0435","volume":"10","author":"NM Sodir","year":"2020","unstructured":"Sodir NM, Kortlever RM, Barthet VJA, et al. MYC instructs and maintains pancreatic adenocarcinoma phenotype. Cancer Discov. 2020;10(4):588\u2013607.","journal-title":"Cancer Discov"},{"key":"6983_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103756","author":"V Llombart","year":"2022","unstructured":"Llombart V, Mansour MR. Therapeutic targeting of \u201cundruggable\u201d MYC. EBioMedicine. 2022. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103756.","journal-title":"EBioMedicine"},{"issue":"12","key":"6983_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrc.2016.105","volume":"16","author":"T Aasen","year":"2016","unstructured":"Aasen T, Mesnil M, Naus CC, et al. Gap junctions and cancer: communicating for 50 years. Nat Rev Cancer. 2016;16(12):775\u201388.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"6983_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/ars.2008.2153","volume":"11","author":"L Cronier","year":"2009","unstructured":"Cronier L, Crespin S, Strale P-O, et al. Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal. 2009;11(2):323\u201338.","journal-title":"Antioxid Redox Signal"},{"issue":"7\u20138","key":"6983_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0248-4900(02)00025-4","volume":"94","author":"M Mesnil","year":"2002","unstructured":"Mesnil M. Connexins and cancer. Biol Cell. 2002;94(7\u20138):493\u2013500.","journal-title":"Biol Cell"},{"issue":"16","key":"6983_CR16","first-page":"4104","volume":"59","author":"DW Laird","year":"1999","unstructured":"Laird DW, Fistouris P, Batist G, et al. Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Can Res. 1999;59(16):4104\u201310.","journal-title":"Can Res"},{"issue":"3","key":"6983_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ijc.26392","volume":"131","author":"S Sirnes","year":"2012","unstructured":"Sirnes S, Bruun J, Kolberg M, et al. Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome. Int J Cancer. 2012;131(3):570\u201381.","journal-title":"Int J Cancer"},{"issue":"9","key":"6983_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1172\/JCI8257","volume":"105","author":"A Ito","year":"2000","unstructured":"Ito A, Katoh F, Kataoka TR, et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest. 2000;105(9):1189\u201397.","journal-title":"J Clin Invest"},{"issue":"6","key":"6983_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3892\/mco.2016.828","volume":"4","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Kimura M, Ishiguro H, et al. Connexin 43 expression is associated with poor survival in patients with esophageal squamous cell carcinoma. Mol Clin Oncol. 2016;4(6):989\u201393.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"6983_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3892\/ijo.2014.2394","volume":"45","author":"P Brockmeyer","year":"2014","unstructured":"Brockmeyer P, Jung K, Perske C, et al. Membrane connexin 43 acts as an independent prognostic marker in oral squamous cell carcinoma. Int J Oncol. 2014;45(1):273\u201381.","journal-title":"Int J Oncol"},{"key":"6983_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-6-20","author":"MK Elzarrad","year":"2008","unstructured":"Elzarrad MK, Haroon A, Willecke K, et al. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med. 2008. https:\/\/doi.org\/10.1186\/1741-7015-6-20.","journal-title":"BMC Med"},{"issue":"3","key":"6983_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1078-0432.CCR-07-1184","volume":"14","author":"K Ezumi","year":"2008","unstructured":"Ezumi K, Yamamoto H, Murata K, et al. Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer. Clin Cancer Res. 2008;14(3):677\u201384.","journal-title":"Clin Cancer Res"},{"key":"6983_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.197","author":"J Yang","year":"2015","unstructured":"Yang J, Qin G, Luo M, et al. Reciprocal positive regulation between Cx26 and PI3K\/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT. Cell Death Dis. 2015. https:\/\/doi.org\/10.1038\/cddis.2015.197.","journal-title":"Cell Death Dis"},{"key":"6983_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02938-1","author":"PS Thiagarajan","year":"2018","unstructured":"Thiagarajan PS, Sinyuk M, Turaga SM, et al. Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-02938-1.","journal-title":"Nat Commun"},{"issue":"6","key":"6983_CR25","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1245\/s10434-009-0443-3","volume":"16","author":"T Inose","year":"2009","unstructured":"Inose T, Kato H, Kimura H, et al. Correlation between connexin 26 expression and poor prognosis of esophageal squamous cell carcinoma. Ann Surg Oncol. 2009;16(6):1704\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"6983_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.canlet.2007.12.008","volume":"262","author":"Y Naoi","year":"2008","unstructured":"Naoi Y, Miyoshi Y, Taguchi T, et al. Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers. Cancer Lett. 2008;262(2):248\u201356.","journal-title":"Cancer Lett"},{"issue":"12","key":"6983_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/carcin\/bgac092","volume":"43","author":"S Yang","year":"2022","unstructured":"Yang S, Tang W, Azizian A, et al. Dysregulation of HNF1B\/clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients. Carcinogenesis. 2022;43(12):1198\u2013210.","journal-title":"Carcinogenesis"},{"issue":"W1","key":"6983_CR28","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"6983_CR29","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng G, Wang E, Wang Z, et al. HawkDock: a web server to predict and analyze the protein-protein complex based on computational docking and MM\/GBSA. Nucleic Acids Res. 2019;47(W1):W322\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"6983_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580\u20135.","journal-title":"Nat Genet"},{"key":"6983_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1146\/annurev-biochem-062917-011931","volume":"87","author":"JAM Bard","year":"2018","unstructured":"Bard JAM, Goodall EA, Greene ER, et al. Structure and function of the 26S proteasome. Ann Rev Biochem. 2018;87:697\u2013724.","journal-title":"Ann Rev Biochem"},{"key":"6983_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-29-79","author":"S Nomura","year":"2010","unstructured":"Nomura S, Maeda K, Noda E, et al. Clinical significance of the expression of connexin26 in colorectal cancer. J Exp Clin Cancer Res. 2010. https:\/\/doi.org\/10.1186\/1756-9966-29-79.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"6983_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3892\/ijmm_00000395","volume":"25","author":"X Liu","year":"2010","unstructured":"Liu X, Furuya T, Li D, et al. Connexin 26 expression correlates with less aggressive phenotype of intestinal type-gastric carcinomas. Int J Mol Med. 2010;25(5):709\u201316.","journal-title":"Int J Mol Med"},{"issue":"2","key":"6983_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.canlet.2005.03.049","volume":"234","author":"A Ito","year":"2006","unstructured":"Ito A, Koma Y, Uchino K, et al. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. Cancer Lett. 2006;234(2):239\u201348.","journal-title":"Cancer Lett"},{"issue":"3","key":"6983_CR35","first-page":"627","volume":"19","author":"N Kyo","year":"2008","unstructured":"Kyo N, Yamamoto H, Takeda Y, et al. Overexpression of connexin 26 in carcinoma of the pancreas. Oncol Rep. 2008;19(3):627\u201331.","journal-title":"Oncol Rep"},{"key":"6983_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01291-6","author":"SK Madden","year":"2021","unstructured":"Madden SK, de Araujo AD, Gerhardt M, et al. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol Cancer. 2021. https:\/\/doi.org\/10.1186\/s12943-020-01291-6.","journal-title":"Mol Cancer"},{"issue":"1","key":"6983_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","volume":"23","author":"M Ala","year":"2022","unstructured":"Ala M. Target c-Myc to treat pancreatic cancer. Cancer Biol Ther. 2022;23(1):34\u201350.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"6983_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ccr.2013.01.023","volume":"23","author":"S Eser","year":"2013","unstructured":"Eser S, Reiff N, Messer M, et al. Selective requirement of PI3K\/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer. Cancer Cell. 2013;23(3):406\u201320.","journal-title":"Cancer Cell"},{"issue":"12","key":"6983_CR39","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1172\/JCI122383","volume":"128","author":"B Madan","year":"2018","unstructured":"Madan B, Harmston N, Nallan G, et al. Temporal dynamics of Wnt-dependent transcriptome reveal an oncogenic Wnt\/MYC\/ribosome axis. J Clin Invest. 2018;128(12):5620\u201333.","journal-title":"J Clin Invest"},{"issue":"2","key":"6983_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41388-020-01525-3","volume":"40","author":"S Zhai","year":"2021","unstructured":"Zhai S, Xu Z, Xie J, et al. Epigenetic silencing of lncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p\/HIPK2\/ERK axis and sequestering IGF2BP1. Oncogene. 2021;40(2):277\u201391.","journal-title":"Oncogene"},{"issue":"26","key":"6983_CR41","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1038\/sj.onc.1208766","volume":"24","author":"T Asano","year":"2004","unstructured":"Asano T, Yao YX, Zhu JJ, et al. The PI 3-kinase\/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-\u03baB and c-Myc in pancreatic cancer cells (vol 23, pg 8517, 2004). Oncogene. 2004;24(26):4320.","journal-title":"Oncogene"},{"key":"6983_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00500-y","author":"C Wang","year":"2021","unstructured":"Wang C, Zhang J, Yin J, et al. Alternative approaches to target Myc for cancer treatment. Signal Transduct Target Ther. 2021. https:\/\/doi.org\/10.1038\/s41392-021-00500-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"6983_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1101\/gad.7.4.671","volume":"7","author":"AC Davis","year":"1993","unstructured":"Davis AC, Wims M, Spotts GD, et al. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 1993;7(4):671\u201382.","journal-title":"Genes Dev"},{"issue":"7737","key":"6983_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41586-018-0736-4","volume":"565","author":"Y Dong","year":"2019","unstructured":"Dong Y, Zhang S, Wu Z, et al. Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome. Nature. 2019;565(7737):49.","journal-title":"Nature"},{"key":"6983_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2018.05.018","volume":"430","author":"Y Li","year":"2018","unstructured":"Li Y, Huang J, Zeng B, et al. PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation. Cancer Lett. 2018;430:109\u201322.","journal-title":"Cancer Lett"},{"issue":"6","key":"6983_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nsmb.1427","volume":"15","author":"R Rosenzweig","year":"2008","unstructured":"Rosenzweig R, Osmulski PA, Gaczynska M, et al. The central unit within the 19S regulatory particle of the proteasome. Nat Struct Mol Biol. 2008;15(6):573\u201380.","journal-title":"Nat Struct Mol Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06983-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:00:25Z","timestamp":1757476825000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06983-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6983"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06983-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical sampling and use processes were based on guidelines released by ethics committee of Zhujiang Hospital, Southern Medical University (approval number: 2025-KY-021). Informed consent was provided by each participant. Our animal experimental protocol gained approval from Animal Experimentation Ethics Committee at Zhujiang Hospital, Southern Medical University (approval number: LAEC-2023\u2013240).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"939"}}